• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TREM2 敲低可提高 PD-1 阻断在肝细胞癌中的治疗效果。

TREM2 knockdown improves the therapeutic effect of PD-1 blockade in hepatocellular carcinoma.

机构信息

Department of General Surgery, NO.215 Hospital of Shaanxi Nuclear Industry, #35 Weiyang West Road, Xianyang, Shaanxi, 712000, China.

Department of General Surgery, NO.215 Hospital of Shaanxi Nuclear Industry, #35 Weiyang West Road, Xianyang, Shaanxi, 712000, China.

出版信息

Biochem Biophys Res Commun. 2022 Dec 25;636(Pt 1):140-146. doi: 10.1016/j.bbrc.2022.10.079. Epub 2022 Oct 25.

DOI:10.1016/j.bbrc.2022.10.079
PMID:36332476
Abstract

Triggering receptor expressed on myeloid cells 2 (TREM2), which is typically expressed in microglia/macrophage, is a crucial receptor modulating the activation of immune cells. Recent single-cell RNA sequencing studies of the tumor microenvironment (TME) have found that TREM2 is highly expressed in several subgroups of tumor-associated macrophages (TAMs) with immunosuppressive activity. TREM2 knockout mice are more resistant to tumor growth than wild-type mice in multiple mice tumor models. But the function of TREM2 expression in TAMs of hepatocellular carcinoma (HCC) is still unclear. Here we used a self-complementary adeno-associated virus (scAAV) with macrophage tropism to efficiently knockdown TREM2 in TAMs in vivo and found that the growth of hepatocellular carcinoma was suppressed by TREM2 knockdown. Moreover, we found that TREM2 knockdown remodeled TAMs to an immune-stimulating status and enhanced the therapeutic effect of PD-1 immune-checkpoint blockade in HCC.

摘要

髓系细胞触发受体 2(TREM2)通常在小胶质细胞/巨噬细胞中表达,是一种调节免疫细胞激活的关键受体。最近对肿瘤微环境(TME)的单细胞 RNA 测序研究发现,TREM2 在具有免疫抑制活性的几种肿瘤相关巨噬细胞(TAM)亚群中高度表达。在多种小鼠肿瘤模型中,TREM2 敲除小鼠比野生型小鼠更能抵抗肿瘤生长。但是,TREM2 在肝癌(HCC)TAM 中的表达功能尚不清楚。在这里,我们使用具有巨噬细胞趋向性的自我互补腺相关病毒(scAAV)在体内有效地敲低 TAMs 中的 TREM2,发现 TREM2 敲低抑制了肝癌的生长。此外,我们发现 TREM2 敲低将 TAMs 重塑为免疫刺激状态,并增强了 HCC 中 PD-1 免疫检查点阻断的治疗效果。

相似文献

1
TREM2 knockdown improves the therapeutic effect of PD-1 blockade in hepatocellular carcinoma.TREM2 敲低可提高 PD-1 阻断在肝细胞癌中的治疗效果。
Biochem Biophys Res Commun. 2022 Dec 25;636(Pt 1):140-146. doi: 10.1016/j.bbrc.2022.10.079. Epub 2022 Oct 25.
2
TREM2 macrophages suppress CD8 T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma.TREM2 巨噬细胞抑制肝癌经动脉化疗栓塞术后 CD8+T 细胞浸润。
J Hepatol. 2023 Jul;79(1):126-140. doi: 10.1016/j.jhep.2023.02.032. Epub 2023 Mar 6.
3
TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy.TREM2 调控重塑肿瘤髓系免疫微环境增强抗 PD-1 免疫治疗。
Cell. 2020 Aug 20;182(4):886-900.e17. doi: 10.1016/j.cell.2020.07.013. Epub 2020 Aug 11.
4
Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.骨桥蛋白诱导集落刺激因子 1 信号破坏肿瘤相关巨噬细胞的迁移,使肝细胞癌对抗 PD-L1 阻断敏感。
Gut. 2019 Sep;68(9):1653-1666. doi: 10.1136/gutjnl-2019-318419. Epub 2019 Mar 22.
5
Integrated Analysis Highlights the Immunosuppressive Role of TREM2 Macrophages in Hepatocellular Carcinoma.综合分析突显了TREM2巨噬细胞在肝细胞癌中的免疫抑制作用。
Front Immunol. 2022 Mar 14;13:848367. doi: 10.3389/fimmu.2022.848367. eCollection 2022.
6
Knockdown of trem2 promotes proinflammatory microglia and inhibits glioma progression via the JAK2/STAT3 and NF-κB pathways.敲低 trem2 通过 JAK2/STAT3 和 NF-κB 通路促进促炎小胶质细胞并抑制神经胶质瘤进展。
Cell Commun Signal. 2024 May 15;22(1):272. doi: 10.1186/s12964-024-01642-6.
7
TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti-PD-1 tumor immunotherapy.TREM2 缺乏重编程肠道巨噬细胞和微生物群,以增强抗 PD-1 肿瘤免疫治疗。
Sci Immunol. 2024 May 17;9(95):eadi5374. doi: 10.1126/sciimmunol.adi5374.
8
Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancer.免疫抑制型 TREM2(+) 巨噬细胞与非小细胞肺癌的不良预后和对 PD-1 免疫治疗的反应相关。
Cancer Immunol Immunother. 2022 Oct;71(10):2511-2522. doi: 10.1007/s00262-022-03173-w. Epub 2022 Mar 12.
9
Galectin-3 induces pathogenic immunosuppressive macrophages through interaction with TREM2 in lung cancer.半乳糖凝集素-3 通过与肺癌中的 TREM2 相互作用诱导致病性免疫抑制性巨噬细胞。
J Exp Clin Cancer Res. 2024 Aug 13;43(1):224. doi: 10.1186/s13046-024-03124-6.
10
Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer.阻断低氧诱导的表达在髓系细胞上的触发受体 1 阳性肿瘤相关巨噬细胞可逆转肝癌中的免疫抑制和抗程序性细胞死亡配体 1 耐药性。
Hepatology. 2019 Jul;70(1):198-214. doi: 10.1002/hep.30593. Epub 2019 Apr 12.

引用本文的文献

1
Qingrehuoxue formula enhances anti-PD-1 immunotherapy in NSCLC by remodeling the tumor immune microenvironment via TREM2 signaling.清热活血方通过TREM2信号重塑肿瘤免疫微环境增强非小细胞肺癌的抗PD-1免疫治疗。
BMC Complement Med Ther. 2025 Jul 16;25(1):270. doi: 10.1186/s12906-025-05020-8.
2
Role of triggering receptor expressed on myeloid cells 2 in the pathogenesis of non-alcoholic fatty liver disease.髓系细胞触发受体2在非酒精性脂肪性肝病发病机制中的作用
World J Hepatol. 2025 Feb 27;17(2):102328. doi: 10.4254/wjh.v17.i2.102328.
3
Biological and clinical role of TREM2 in liver diseases.
TREM2在肝脏疾病中的生物学及临床作用
Hepatol Commun. 2024 Nov 15;8(12). doi: 10.1097/HC9.0000000000000578. eCollection 2024 Dec 1.
4
Bibliometric Analysis of TREM2 (2001-2022): Trends, Hotspots and Prospects in Human Disease.TREM2的文献计量分析(2001 - 2022):人类疾病的趋势、热点与前景
Int J Med Sci. 2024 Jul 16;21(10):1852-1865. doi: 10.7150/ijms.96851. eCollection 2024.
5
Single-Cell RNA Sequencing Identifies Crucial Genes Influencing the Polarization of Tumor-Associated Macrophages in Liver Cancer.单细胞RNA测序鉴定影响肝癌中肿瘤相关巨噬细胞极化的关键基因。
Int J Genomics. 2024 May 25;2024:7263358. doi: 10.1155/2024/7263358. eCollection 2024.
6
Transcriptomic and genomic characteristics of intrahepatic metastases of primary liver cancer.原发性肝癌肝内转移的转录组学和基因组学特征。
BMC Cancer. 2024 Jun 1;24(1):672. doi: 10.1186/s12885-024-12428-x.
7
Mechanisms of TREM2 mediated immunosuppression and regulation of cancer progression.TREM2介导的免疫抑制及癌症进展调控机制
Front Oncol. 2024 Apr 25;14:1375729. doi: 10.3389/fonc.2024.1375729. eCollection 2024.
8
The role of tumor-associated macrophages in hepatocellular carcinoma progression: A narrative review.肿瘤相关巨噬细胞在肝细胞癌进展中的作用:叙述性综述。
Cancer Med. 2023 Dec;12(24):22109-22129. doi: 10.1002/cam4.6717. Epub 2023 Dec 14.
9
Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病中肝细胞癌的非实质细胞与细胞外基质
Cancers (Basel). 2023 Feb 18;15(4):1308. doi: 10.3390/cancers15041308.
10
The emerging role of triggering receptor expressed on myeloid cell-2 in malignant tumor.髓样细胞2上表达的触发受体在恶性肿瘤中的新作用。
Cent Eur J Immunol. 2022;47(4):373-381. doi: 10.5114/ceji.2022.124387. Epub 2023 Jan 31.